DE3481172D1 - Verfahren und materialien zum empfindlichmachen eines neoplastischen gewebes vor strahlung. - Google Patents

Verfahren und materialien zum empfindlichmachen eines neoplastischen gewebes vor strahlung.

Info

Publication number
DE3481172D1
DE3481172D1 DE8484904049T DE3481172T DE3481172D1 DE 3481172 D1 DE3481172 D1 DE 3481172D1 DE 8484904049 T DE8484904049 T DE 8484904049T DE 3481172 T DE3481172 T DE 3481172T DE 3481172 D1 DE3481172 D1 DE 3481172D1
Authority
DE
Germany
Prior art keywords
sensitivating
materials
neoplastic tissue
tissue before
before radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484904049T
Other languages
German (de)
English (en)
Inventor
Sheldon B Greer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Halogenetics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3481172D1 publication Critical patent/DE3481172D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8484904049T 1983-10-26 1984-10-26 Verfahren und materialien zum empfindlichmachen eines neoplastischen gewebes vor strahlung. Expired - Lifetime DE3481172D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54569383A 1983-10-26 1983-10-26
PCT/US1984/001735 WO1985001871A1 (en) 1983-10-26 1984-10-26 Method and materials for sensitizing neoplastic tissue to radiation

Publications (1)

Publication Number Publication Date
DE3481172D1 true DE3481172D1 (de) 1990-03-08

Family

ID=24177186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484904049T Expired - Lifetime DE3481172D1 (de) 1983-10-26 1984-10-26 Verfahren und materialien zum empfindlichmachen eines neoplastischen gewebes vor strahlung.

Country Status (5)

Country Link
EP (1) EP0160079B1 (enExample)
JP (1) JPS61500224A (enExample)
AU (1) AU583801B2 (enExample)
DE (1) DE3481172D1 (enExample)
WO (1) WO1985001871A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4815448A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
US4815447A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
JP2785025B2 (ja) 1985-03-19 1998-08-13 ランデル・エル・ミルズ 診断と選択的組織壊死を与える装置
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
US6417168B1 (en) * 1998-03-04 2002-07-09 The Trustees Of The University Of Pennsylvania Compositions and methods of treating tumors
ES2273672T3 (es) * 1999-03-01 2007-05-16 Halogenetics, Inc. Uso de composiciones que comprenden cldc como radiosensibilizadores en el tratamiento de enfermedades neoplasticas.
US6933287B1 (en) 1999-03-01 2005-08-23 Sheldon B. Greer Dramatic simplification of a method to treat neoplastic disease by radiation
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
TWI477508B (zh) * 2009-04-06 2015-03-21 Otsuka Pharma Co Ltd 用以治療癌症之組成物及方法
EP2416781B1 (en) 2009-04-06 2017-03-08 Otsuka Pharmaceutical Co., Ltd. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
UY32546A (es) 2009-04-06 2010-10-29 Eisai Inc Composiciones y metodos para tratar cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870700A (en) * 1973-05-29 1975-03-11 Miles Lab 2-halogeno-2-deoxy-5-(substituted)uridines
US4017606A (en) * 1973-10-04 1977-04-12 The Upjohn Company Organic compounds and process
CS184526B1 (en) * 1976-02-19 1978-08-31 Dieter Cech 2'-halogen-2'-deoxy-5-fluoruridine,3',5-di-o-benzoyl-derivatives and process for preparing thereof
US4210638A (en) * 1978-03-17 1980-07-01 Pcr, Inc. Antiviral composition and method of treating virus diseases

Also Published As

Publication number Publication date
JPH0586376B2 (enExample) 1993-12-10
EP0160079A4 (en) 1986-05-14
WO1985001871A1 (en) 1985-05-09
EP0160079B1 (en) 1990-01-31
JPS61500224A (ja) 1986-02-06
AU583801B2 (en) 1989-05-11
AU3610784A (en) 1985-05-22
EP0160079A1 (en) 1985-11-06

Similar Documents

Publication Publication Date Title
DE3772025D1 (de) Apparat und verfahren zum zufuehren eines verpackungsfilms.
AT380783B (de) Verfahren und einrichtung zum heben eines patienten
DE69016588D1 (de) Methode und Apparat zum Schneiden eines Rohres.
DD129826A5 (de) Verfahren und apparat zum untersuchen einer fluessigkeit
DE3582572D1 (de) Verfahren und vorrichtung zum herstellen eines schichtkoerpers.
DE68917266D1 (de) Apparat und Verfahren zum Herstellen von absorbierenden Materialien.
AT379280B (de) Verfahren zum herstellen von leiterplatten mit starren und flexiblen bereichen
DK0605395T3 (da) Apparat og fremgangsmåde til fremstilling af en fluid beregnet til medicinsk brug
DE3381655D1 (de) Verfahren und einrichtung zum aufbereiten eines rasteranzeigegeraetes.
DE68923713D1 (de) Verfahren und Vorrichtung zum provisorischen Verschweissen eines Deckels.
ATE12176T1 (de) Verfahren zum herstellen eines haarwuchsmittels.
AT387359B (de) Verfahren und vorrichtung zum aufbauen eines luftreifens
DE3463183D1 (en) Method and apparatus for the detection of composition changes within a fluid using ultransonic means
DE3788079D1 (de) Verfahren und Vorrichtung zum Ausstreichen eines Kulturmediums.
DE3481345D1 (de) Verfahren und vorrichtung zur akustischen holographie bei verwendung eines raeumlich begrenzten ultraschallstrahlenbuendels.
DE3583365D1 (de) Strahlungssonde und verfahren zum gebrauch derselben.
ATA238681A (de) Verfahren zum herstellen eines einfachen lagermaterials
DE3579606D1 (de) Verfahren und vorrichtung zum trocknen eines fluessigen materials.
DE3679981D1 (de) Transmissionsprojektionsschirm und verfahren zum herstellen eines schirmes.
DE3381728D1 (de) Verfahren zum speichern und zur wiedergabe eines strahlungsbildes.
DE3578922D1 (de) Verfahren und vorrichtung zum aufweiten eines rohres.
EP0160079A4 (en) METHOD AND MATERIALS FOR SENSITIZING NEOPLASTIC TISSUE TO IRRADIATION.
GB2003659B (en) Method and apparatus for testing a fluid
DE3381828D1 (de) Verfahren zum speichern und zur wiedergabe eines strahlungsbildes.
DE3673045D1 (de) Schirm zum speichern eines strahlungsbildes und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HALOGENETICS INC., AVENTURA, FLA., US

8381 Inventor (new situation)

Free format text: GREER, SHELDON B., MIAMI, FLA., US

8339 Ceased/non-payment of the annual fee